AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro
Covered by 2 sources
Read the full articleAstraZeneca has entered a deal with AI drug discovery firm Insitro, paying $40 million upfront and potentially up to $1.5 billion if milestones are met, to advance AI-driven therapeutics.
